ZA87185B - Omega-((hetero)alkyl)benz(cd)indol-2-amines - Google Patents

Omega-((hetero)alkyl)benz(cd)indol-2-amines

Info

Publication number
ZA87185B
ZA87185B ZA87185A ZA87185A ZA87185B ZA 87185 B ZA87185 B ZA 87185B ZA 87185 A ZA87185 A ZA 87185A ZA 87185 A ZA87185 A ZA 87185A ZA 87185 B ZA87185 B ZA 87185B
Authority
ZA
South Africa
Prior art keywords
benz
indol
omega
hetero
alkyl
Prior art date
Application number
ZA87185A
Other languages
English (en)
Inventor
Andrew Stephen Tomcufcik
Walter Edward Meyer
Peter Sinchun Chan
David Leroy Crandall
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA87185B publication Critical patent/ZA87185B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
ZA87185A 1986-01-13 1987-01-12 Omega-((hetero)alkyl)benz(cd)indol-2-amines ZA87185B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/818,315 US4728663A (en) 1986-01-13 1986-01-13 N-[(1H-imidazol-1-yl)alkyl]benz[cd]-indol-2-amines and use in inhibiting thromboxane synthetase enzyme

Publications (1)

Publication Number Publication Date
ZA87185B true ZA87185B (en) 1988-07-27

Family

ID=25225236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87185A ZA87185B (en) 1986-01-13 1987-01-12 Omega-((hetero)alkyl)benz(cd)indol-2-amines

Country Status (15)

Country Link
US (1) US4728663A (xx)
EP (1) EP0230035B1 (xx)
JP (1) JPS62215582A (xx)
KR (1) KR900002756B1 (xx)
AT (1) ATE112771T1 (xx)
AU (1) AU604223B2 (xx)
CA (1) CA1317948C (xx)
DE (1) DE3650096D1 (xx)
DK (1) DK12487A (xx)
FI (1) FI92063C (xx)
HU (1) HU198924B (xx)
NO (1) NO168035C (xx)
NZ (1) NZ218879A (xx)
PH (1) PH23606A (xx)
ZA (1) ZA87185B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081131A (en) * 1986-01-13 1992-01-14 American Cyanamid Company Omega-((hetero)alkyl)benz(cd)-indol-2-amines

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229237B (it) * 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
US5079247A (en) * 1990-03-14 1992-01-07 American Cyanamid Company N1 -substituted benz(cd)indol-2-imine compounds as cardiovascular agents
GB9127304D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US6077460A (en) * 1996-07-17 2000-06-20 Basf Aktiengesellschaft Corrosion inhibition
DE19628893A1 (de) * 1996-07-17 1998-01-22 Basf Ag Verwendung von 1-Amidoalkylimidazolen als Korrosionsinhibitoren in der petrochemischen Industrie und Verfahren zu deren Herstellung
KR20010052171A (ko) 1998-04-02 2001-06-25 알. 제이. 레이놀즈 터베코 컴퍼니 의약 조성물 및 그 사용방법
US20010031771A1 (en) 1999-05-24 2001-10-18 Gary Maurice Dull Pharmaceutical compositions and methods for use
US6403581B1 (en) 2000-01-19 2002-06-11 American Cyanamid Company Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives
CN105985282B (zh) * 2015-01-28 2020-12-08 中国科学院广州生物医药与健康研究院 一种2-氧代-1,2-二氢苯并[cd]吲哚类化合物及其应用
CN114349684B (zh) * 2022-01-19 2023-03-28 西南林业大学 一种苯并[c,d]吲哚亚胺衍生物的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1388599A (fr) * 1963-04-20 1965-02-05 Bayer Ag Colorants nouveaux et procédé pour les fabriquer et les appliquer
DE2608020A1 (de) * 1976-02-27 1977-09-01 Bayer Ag Naphthostyrilfarbstoffe
DK335477A (da) * 1976-08-03 1978-02-04 Sandoz Ag Fremgangsmaade til fremstilling af benz(cd)indolylderivater
US4261896A (en) * 1979-11-23 1981-04-14 American Cyanamid Company 1-Substituted-2-(substituted-imino)-1H-1,2-dihydrobenz[cd]indoles
US4259490A (en) * 1980-06-23 1981-03-31 American Cyanamid Company 2-(Substituted amino)benz[cd]indoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081131A (en) * 1986-01-13 1992-01-14 American Cyanamid Company Omega-((hetero)alkyl)benz(cd)-indol-2-amines

Also Published As

Publication number Publication date
NO168035B (no) 1991-09-30
DK12487D0 (da) 1987-01-12
AU604223B2 (en) 1990-12-13
HUT43059A (en) 1987-09-28
FI92063B (fi) 1994-06-15
NZ218879A (en) 1990-12-21
JPS62215582A (ja) 1987-09-22
CA1317948C (en) 1993-05-18
EP0230035A3 (en) 1990-01-10
HU198924B (en) 1989-12-28
KR870007158A (ko) 1987-08-17
KR900002756B1 (ko) 1990-04-28
AU6749387A (en) 1987-07-16
FI870100A0 (fi) 1987-01-12
NO870111L (no) 1987-07-14
EP0230035B1 (en) 1994-10-12
NO168035C (no) 1992-01-08
US4728663A (en) 1988-03-01
DK12487A (da) 1987-07-14
FI870100A (fi) 1987-07-14
ATE112771T1 (de) 1994-10-15
DE3650096D1 (de) 1994-11-17
NO870111D0 (no) 1987-01-12
FI92063C (fi) 1994-09-26
EP0230035A2 (en) 1987-07-29
PH23606A (en) 1989-09-11

Similar Documents

Publication Publication Date Title
MY103189A (en) Nor-statine and nor-cyclostatine polypeptides
NO872589D0 (no) Noeytrale metalloendopeptidaseinhibitorer for behandling av hypertensjon.
PH23606A (en) Omega-((hetero)alkyl)benz(cd)indol-2-amines
AU2492988A (en) Inhibitors of non-enzymatic cross-linking
AU3303789A (en) Method for determining state of malignant and pre-malignant progression
AU7327287A (en) Delayed/sustained release of macromolecules
JO1379B1 (en) Derivative of indole compound
DK317287D0 (da) Reduktase-inhibitorer
AU6613990A (en) Thiazolidine derivatives for the treatment of hypertension
EP0354587A3 (en) Power saving low frequency power amplifier
EP0599514A3 (en) Pyranoquinoline derivatives as inhibitors of cell proliferation.
MY104354A (en) Non-peptidic renin inhibitors
EP0199447A3 (en) Apparatus for the detection and destruction of incoming objects
AU3359493A (en) Determination of haptens
IL92618A0 (en) Dipeptide derivatives having an enzyme inhibitor action
ES8205126A1 (es) Un procedimiento para la preparacion de un inhibidor del enzima convertidor de la angiotensina.
IT1229975B (it) Coperchi per una migliorata crescita di nastri dendritici.
ES2012958A6 (es) Procedimiento para preparar derivados de cisteina.
PL251506A1 (en) Method of detecting growth of malignant neoplasm cells
KR910016232A (ko) 헤테로사이클릭 화합물과 말레이미드와의 공중합체 및 이의 제조방법
AU6503390A (en) Carboxyalkyl dipeptide inhibitors of endopeptidases
ZA874487B (en) Novel hmg-coa reductase inhibitors
AU589432B2 (en) Heterocyclic pentalene derivatives for use in combating microorganisms
AU4219689A (en) Treatment for malignant melanoma
GR890100710A (en) Membered heterocyclic ring angiotensin converting enzyme inhibitors